Author

M. E. T. Mendes

h-index 2 View on Semantic Scholar

We have 3 of 20 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access 2026

Prognostic impact of her2-low status in patients with breast cancer: a systematic review of the literature

Introduction: Breast cancer (BC) is a biologically heterogeneous disease and HER2 expression presents important prognostic implications. Recently, the HER2-low BC has been recognized, defined as HER2 immunohistochemistry (IHC) 1+ or 2+ without gene amplification, whereas HER2-zero tumors show no detectable expression....

Deborah Abucarma Soares, M. E. T. Mendes, A. Carvalho et al. · Mastology · 0 citations

Review Open access 2026

Prognostic value of androgen receptor expression in triple-negative breast cancer: a systematic review and meta-analysis

Introduction: Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) expression, with limited therapeutic options. TNBC exhibits high tumor heterogeneity and a worse prognosis, including...

Vyvian Paes de Oliveira, Deborah Abucarma Soares, M. E. T. Mendes et al. · Mastology · 0 citations

Review Open access 2026

Omission of the sentinel lymph node after neoadjuvant chemotherapy in breast cancer

SLNB after chemotherapy is effective in suspected axillary involvement, and has been proven effective in patients without lymph node metastases and in those with recurrence, especially when ≥3 negative sentinel nodes are identified.

M. E. T. Mendes, Elisa de Araujo Meireles Lewergger, Sophia Fonseca Chagas et al. · Mastology · 0 citations